BARTOLINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 18.745
NA - Nord America 14.097
AS - Asia 5.426
SA - Sud America 716
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 150
OC - Oceania 139
Totale 39.450
Nazione #
US - Stati Uniti d'America 13.877
PL - Polonia 11.364
RU - Federazione Russa 2.261
IT - Italia 1.626
SG - Singapore 1.522
CN - Cina 1.293
SE - Svezia 740
HK - Hong Kong 704
VN - Vietnam 680
IE - Irlanda 670
BR - Brasile 595
UA - Ucraina 507
KR - Corea 485
DE - Germania 450
FI - Finlandia 326
GB - Regno Unito 300
FR - Francia 275
IN - India 159
AU - Australia 136
CA - Canada 130
ID - Indonesia 106
JP - Giappone 92
TR - Turchia 92
NL - Olanda 64
BD - Bangladesh 57
JO - Giordania 50
AR - Argentina 45
CI - Costa d'Avorio 42
IQ - Iraq 35
MX - Messico 34
SC - Seychelles 34
PT - Portogallo 27
ZA - Sudafrica 23
CH - Svizzera 22
ES - Italia 22
PK - Pakistan 22
BE - Belgio 20
SA - Arabia Saudita 17
CO - Colombia 16
MA - Marocco 16
NG - Nigeria 14
AT - Austria 13
TH - Thailandia 13
AZ - Azerbaigian 12
EC - Ecuador 12
PE - Perù 12
PY - Paraguay 12
EG - Egitto 11
LT - Lituania 11
NP - Nepal 11
CR - Costa Rica 10
JM - Giamaica 9
PH - Filippine 9
TN - Tunisia 9
UZ - Uzbekistan 9
VE - Venezuela 9
IL - Israele 8
PR - Porto Rico 8
BG - Bulgaria 7
CL - Cile 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
KE - Kenya 7
RO - Romania 7
TW - Taiwan 7
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
LB - Libano 5
OM - Oman 5
BH - Bahrain 4
BJ - Benin 4
ET - Etiopia 4
HR - Croazia 4
LV - Lettonia 4
PA - Panama 4
AM - Armenia 3
AO - Angola 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
IR - Iran 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
GP - Guadalupe 2
HN - Honduras 2
IS - Islanda 2
MD - Moldavia 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
Totale 39.286
Città #
Warsaw 11.356
Santa Clara 1.983
Ashburn 1.731
Fairfield 1.092
Singapore 1.064
Jacksonville 745
Dublin 666
Chandler 607
Hong Kong 566
Woodbridge 506
Seattle 477
Cambridge 457
San Jose 453
Council Bluffs 442
Wilmington 409
Seoul 390
Houston 387
Milan 351
Beijing 287
Hefei 261
The Dalles 240
Dong Ket 223
Los Angeles 193
Altamura 170
Princeton 167
Ann Arbor 165
Buffalo 160
Boardman 154
Lawrence 137
Ho Chi Minh City 129
Lauterbourg 129
Helsinki 125
Dallas 123
Boston 119
Rome 114
Hanoi 110
Melbourne 109
Mumbai 104
Paris 97
Jakarta 94
San Diego 92
Phoenix 89
Tokyo 83
Medford 74
Moscow 73
New York 73
Seongnam 73
Munich 70
Shanghai 68
Izmir 62
Columbus 60
Florence 60
Falls Church 55
São Paulo 48
Springfield 46
Kent 43
Abidjan 42
Washington 40
Turin 38
London 35
Frankfurt am Main 33
Guangzhou 33
Figino 32
Naples 32
Montreal 29
Chicago 28
Hillsboro 28
Orem 28
Turku 28
Frankfurt Am Main 26
Norwalk 26
Auburn Hills 25
Palermo 24
Verona 24
West Jordan 24
Amsterdam 23
Brooklyn 22
San Francisco 21
Bern 20
Bologna 20
Brussels 20
Philadelphia 20
Redondo Beach 20
Groningen 19
Miano 19
Tianjin 19
Andover 18
Atlanta 18
Dearborn 18
Toronto 18
Boydton 17
Baghdad 16
Guimarães 16
Las Vegas 16
Bari 15
North Bergen 15
Zhengzhou 15
Da Nang 14
Yubileyny 14
Denver 13
Totale 29.182
Nome #
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 684
M1 receptor activation is a requirement for arecoline analgesia. 629
Antinociceptive property of the nicotinic agonist AG4 in rodents 530
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 489
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 444
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 428
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 428
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 415
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 414
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 403
Ryanodine receptors are involved in muscarinic antinociception in mice. 399
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 399
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 398
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 394
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 381
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 379
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 366
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 364
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 361
Local anaesthetic activity of beta-caryophyllene. 350
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 348
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 346
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 341
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 340
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 339
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 338
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 335
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 333
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 333
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 328
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 326
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 325
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 324
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 323
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 322
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 322
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 321
Effect of K+ channel modulation on mouse feeding behaviour 317
Role of intracellular calcium in acute thermal pain perception 317
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 316
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 316
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 315
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 311
Prochlorperazine induces central antinociception mediated by the muscarinic system. 310
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 308
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 307
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 307
Influence of potassium channel modulators on cognitive processes in mice 305
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 304
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 304
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 304
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 304
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 303
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 303
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 302
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 302
Caffeine induces central cholinergic analgesia. 302
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 300
Memory facilitation with atropine: a paradoxical effect 300
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 296
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 294
Endogenous morphine modulates acute thermonociception in mice. 294
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 293
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 293
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 292
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 291
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 290
In vitro characterization of a novel, potent and selective M3 antagonist 290
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 290
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 287
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 285
Neuropathy-induced apoptosis: Protective effect of physostigmine 282
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 280
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 279
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 279
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat 277
PHARMACOLOGICAL IDENTIFICATION OF SM-21, THE NOVEL SIGMA2 ANTAGONIST 276
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 268
Antagonism by piracetam of baclofen antinociception 262
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. 256
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 255
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors 249
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 248
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 248
ANTINOCICEPTION INDUCED BY AMITRIPTYLINE AND IMIPRAMINE IS MEDIATED BY A2A-ADRENOCEPTORS 245
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits. 223
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression 217
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram). 216
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 215
INVESTIGATION INTO THE ROLE OF HISTAMINE RECEPTORS IN RODENT ANTINOCICEPTION 211
S-(-)-ET126: a potent and selective M1 antagonist 203
Gi/o proteins: expression for direct activation enquiry 200
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 198
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 192
R-(+)-HYOSCYAMINE: A PERIPHERAL CHOLINERGIC AMPLIFER 190
INVOLVEMENT OF CENTRAL CHOLINERGIC NEUROTRANSMISSION IN METOCLOPRAMIDE ANALGESIA 188
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 188
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 187
Role of histamine in rodent antinociception 186
Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy 186
Totale 31.255
Categoria #
all - tutte 89.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.267 0 155 106 36 65 74 55 75 77 86 247 291
2022/20232.779 261 464 135 206 241 505 383 158 257 13 102 54
2023/20241.453 57 132 219 72 81 228 48 449 29 49 45 44
2024/20256.621 241 684 416 892 1.815 824 134 368 299 273 430 245
2025/20268.599 834 1.098 673 422 852 442 1.012 468 584 668 429 1.117
2026/2027707 335 372 0 0 0 0 0 0 0 0 0 0
Totale 39.450